Commentary

Article

Top 5 Pharmacy Times Clostridioides difficile Articles of 2023

From newsworthy moments to groundbreaking research, these were the most-read Clostridioides difficile-related articles on Pharmacy Times in 2023.

1. Community-associated C. Difficile Infection Is Rising; Disease Carries Significant Social, Economic Burden

Clostridioides difficile infection can have a significant impact on feelings of depression and anxiety, while worsening quality of life. Read More Here.

Bacteria Clostridioides difficile | Image Credit: Dr_Microbe - stock.adobe.com

Dr_Microbe - stock.adobe.com

2. Clinical Overview: Steps to Implementation of Rebyota for Recurrent C. difficile Infection

Rebyota is a live biotherapeutic product that is unfamiliar to many pharmacists and other health care providers, and it has unique steps in the administration process. Read More Here.

3. Open-Label Clinical Trials Have Higher Cure Rate of Recurrent C. Diff Infection Compared to Randomized Clinical Trials

Randomized clinical trials still showed that microbiota restoration is significantly more effective than antibiotics for recurrent Clostridioides difficile infection. Read More Here.

4. Phase 2 Trial Data Show That Novel Antibiotic Led to 96% Cure Rate for C diff Infection

Iberzaplstat was non-inferior to standard of care vancomycin, was safe and tolerable, and will advance into a phase 3 trial. Read More Here.

5. Common Antibiotics Associated with C. difficile Infection Include Piperacillin, Meropenem

Antibiotics that were found to be most commonly associated with Clostridioides difficile infection are piperacillin/tazobactam, meropenem, vancomycin, ciprofloxacin, ceftriaxone, and levofloxacin, according to a recent study. Read More Here.

Related Videos
Image credit: Peter Hansen | stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
Pharmacy, Advocacy, Opioid Awareness Month | Image Credit: pikselstock - stock.adobe.com
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Hurricane Helene, Baxter plant, IV fluids shortage, health systems impact, injectable medicines, compounding solutions, patient care errors, clinical resources, operational consideration, fluid conservation, sterile water, temperature excursions, training considerations, patient safety, feedback request
Image Credit: © peopleimages.com - stock.adobe.com